Shree Salasar Investments has officially allotted 1.85 million convertible warrants at Rs 175 each, raising Rs 32.37 crore. The issuance, involving both promoter and non-promoter entities, allows for conversion into equity shares within 18 months. This move expands the company's capital structure plans and will lead to potential equity dilution once conversion occurs.
Shree Salasar Investments Completes 1.85 Million Warrant Allotment
1,850,000 warrants allotted at Rs 175 per unit. Aggregate value of the issuance is Rs 32.375 crore.
Reader Takeaway: This capital raise strengthens growth funding but signals future equity dilution upon conversion within 18 months.
What just happened
Shree Salasar Investments Limited has formally allotted 1,850,000 convertible warrants on a preferential basis following board approval on October 21, 2026. The issuance was distributed among four identified allottees, including members of the promoter group and non-promoters. The company previously secured in-principle approval from the BSE on October 13, 2026, for this transaction.
Key Terms of the Issuance
The warrants are priced at Rs 175 per warrant, carrying a face value of Rs 10 per share. Each warrant grants the holder the right to receive one equity share upon payment of the remaining 75% of the issue price. The conversion must be exercised within 18 months from the date of allotment.
Capital Structure Impact
Currently, the allotment does not alter the paid-up equity share capital. However, the company notes that upon the eventual conversion, the issued equity shares will rank pari passu with existing shares. This transition will lead to an expansion of the total equity base and a dilution of the existing shareholding percentage.
Allotment Breakdown
- Ajay Dilkush Sarupria: 900,000 warrants
- Shailesh Ginsulal Hingarh: 900,000 warrants
- Harshad Sobhagchand Dholakia: 25,000 warrants
- Seeta Harshad Dholakia: 25,000 warrants
What to track next
Shareholders should track the company’s announcements regarding the conversion of these warrants over the next 18 months, as these events will officially impact the equity capital base and the company's EPS figures.